Updated: Jun 18, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Kevin Caili Wang1, Xinwei Wang, Pingyu Zhong
1Abmaxis Inc., a wholly owned subsidiary of Merck & Co, Inc, WP26-413, 770 Sumneytown Pike, West Point, PA 19486, USA. kevin_wang@merck.com
A novel adapter-directed phage display system enables modular protein presentation on phage surfaces. This versatile platform allows target proteins to be displayed on various phage coat proteins and formats, enhancing biopaneling applications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: